GoodRx Holdings (GDRX) R&D US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
R&D, bln rub | 61.8 | 125.9 | 143.1 | 143.1 | 135.8 | 123.5 | |||
Changes by years, y/y, % | +111% | +104% | +14% | 0% | -5% | +25.3% |
GoodRx Holdings. R&D, bln rub
GoodRx Holdings. R&D, changes, %
GoodRx Holdings. R&D, sum by quarters, bln rub
GoodRx Holdings (GDRX) R&D US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
R&D, bln rub | 39.6 | 31.5 | 31.0 | 30.9 | 30.1 | 123.5 | ||
Changes by years, y/y, % | +10% | -14% | -6% | -1% | -24% | |||
Changes by quarters, q/q, % | +27% | -20% | -2% | -1% | -2% |